Table 1.

Clinical and molecular pathology features of Glioma samples in association with RP11-732 M18.3 expression.

	Low	High	P
Gender, female/male	12/10	17/19	0.588
Age at diagnosis, y	33.46 ± 16.29	49.66 ± 12.94	0.469
IDH1 mutation (no mutation/mutation)	14/8	15/21	0.104
MGMT promoter methylation (unmethylation/methylation)	13/9	13/23	0.088
Ki-67 (low/high)	15/7	12/24	0.010⁎

^⁎P values <.05 were considered statistically significant.